US biotech firm Moderna (Nasdaq: MRNA) shares rose by over 4% on Tuesday to close at $24.84 (£18.2) despite US equity indexes slipping from their record high ahead of the US Federal Reserve's decision on interest rates. The Federal Open Market Committee is expected to make the announcement today.
The primary reason Moderna shares gained yesterday was its announcement of positive results for the newest formula of Spikewax to help prevent COVID-19.
